Read real stories from people affected by MND, get inspired by the incredible ways people are supporting our cause and hear more about the latest advancements in research, care and support.​


MND Scotland Trustee, Professor Richard Ribchester on the progress of MND research

To mark National Research Appreciation Day, our trustee, Professor Richard Ribchester, shares his thoughts on the progress and future of motor neuron disease (MND) research. 

New research project could improve MND diagnosis, monitoring and research

The new research project, run by Professor Roger Whittaker, a consultant clinical neurophysiologist at the University of Newcastle, will investigate whether it is possible to lay the foundations for a non-invasive investigation using standard hospital MRI scanners.

The grant review process; perspective of an Early Career Researcher

Dr Hannah Smith, a postdoctoral motor neuron disease (MND) researcher at the University of Edinburgh, has been an observatory, non-voting member involved in MND Scotland’s grant reviews since January 2024.

MND Scotland launches network to connect people with MND and researchers

Ahead of Global MND Awareness Day on Friday, 21 June, MND Scotland has launched a network of events to bring together researchers and people with, and affected by, motor neuron disease.

Clinical Academic Fellowship Announced for MND Research

MND Scotland and the Scottish Government’s Chief Scientist Office have appointed a three-year Clinical Academic Fellow to investigate potential causes of, and therapies for, motor neuron disease (MND).

New researcher joins MND Pre-Fellowship scheme with project focused on biomarkers

A new research project has launched as part of the Pre-Fellowship scheme to fund MND research leaders of the future.  

MND charities update on MIROCALS

In February, the three main MND charities shared an update that stated we had written a joint letter to regulators alerting them to the imminent publication of the data.  

MND charities respond to TUDCA trial results

Phase 3 clinical trial of tauroursodeoxycholic acid (TUDCA) fails to meet primary aim of reducing the progression of MND.

National Institute for Health and Care Excellence (NICE) Confirms Tofersen Drug Appraisal via STA Route